High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients (Q37009902)

17 August 2017

High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients (English)

1 reference

17 August 2017

0 references

7

Julia Parrish

1 reference

17 August 2017

Laila Abdullah

1

1 reference

17 August 2017

Cheryl Luis

2

1 reference

17 August 2017

Daniel Paris

3

1 reference

17 August 2017

Ghania Ait-ghezala

4

1 reference

17 August 2017

Benoit Mouzon

5

1 reference

17 August 2017

Elizabeth Allen

6

1 reference

17 August 2017

Myles A Mullan

8

1 reference

17 August 2017

Scott Ferguson

9

1 reference

17 August 2017

Marcie Wood

10

1 reference

17 August 2017

Fiona Crawford

11

1 reference

17 August 2017

Michael Mullan

12

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

17 August 2017

1 reference

17 August 2017

15

1 reference

17 August 2017

3-4

1 reference

17 August 2017

95-100

1 reference

No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Effects of medications on plasma amyloid beta (Abeta) 42: longitudinal data from the VITA cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Cardiovascular Risk Factors for Alzheimer's Disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Molecular genetics of Alzheimer's disease: the role of beta-amyloid and the presenilins.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Midlife blood pressure and dementia: the Honolulu-Asia aging study.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Reduced risk of incident AD with elective statin use in a clinical trial cohort

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Plasma Abeta42 correlates positively with increased body fat in healthy individuals.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Familial clustering and genetic risk for dementia in a genetically isolated Dutch population

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Serum creatinine levels correlate with plasma amyloid Beta protein

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Confirmation that familial clustering and age of onset in late onset Alzheimer's disease are determined at the apolipoprotein E locus.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

High density lipoproteins bind Aβ and apolipoprotein C-II amyloid fibrils

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2600489

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

4 December 2018

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

15-year longitudinal study of blood pressure and dementia

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

Characterization of apolipoprotein J-Alzheimer's A beta interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.2119%2FMOLMED.2008.00118

Transthyretin in high density lipoproteins: association with apolipoprotein A-I

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19081767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Analysis of apolipoprotein E genotypes by the Amplification Refractory Mutation System

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19081767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19081767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2119/MOLMED.2008.00118

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

PubMed publication ID

19081767

1 reference